Akamai Technologies Available For Sale Securities Debt Securities Current increased by 22.0% to $302.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.8%, from $211.97M to $302.74M. Over 4 years (FY 2020 to FY 2025), Available For Sale Securities Debt Securities Current shows a downward trend with a -24.0% CAGR.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q3 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $651.93M | $562.31M | $452.79M | $491.63M | $475.32M | $372.01M | $1.20B | $1.18B | $1.12B | $1.07B | $211.97M | $103.77M | $176.78M | $248.17M | $302.74M |
| QoQ Change | — | -13.7% | -19.5% | +8.6% | -3.3% | -21.7% | +222.9% | -1.6% | -5.2% | -4.5% | -80.2% | -51.0% | +70.4% | +40.4% | +22.0% |
| YoY Change | — | — | — | — | — | -33.8% | +165.3% | +140.3% | +135.6% | +187.5% | -82.4% | -91.2% | -84.2% | -76.8% | +42.8% |